Emergent Biosolutions Inc (EBS) concluded trading on Wednesday at a closing price of $2.71, with 76.04 million shares of worth about $206.06 million changed hands on the day. Half year performance of the stock remained negative as price took a plunge of -43.07% during that period and on Wednesday the price saw a gain of about 78.29%. Currently the company’s common shares owned by public are about 50.10M shares, out of which, 49.75M shares are available for trading.
According to filings with the U.S. Securities and Exchange Commission (SEC), insiders took part in trade of the company’s stock for 60 times over the past 12 months. They bought 1,130,526 shares in 35 of the transactions. In 25 selling transactions, insiders dumped 20,209 shares.
3 Tiny Stocks Primed to Explode
The world's greatest investor — Warren Buffett — has a simple formula for making big money in the markets. He buys up valuable assets when they are very cheap. For stock market investors that means buying up cheap small cap stocks like these with huge upside potential.
We've set up an alert service to help smart investors take full advantage of the small cap stocks primed for big returns.
Click here for full details and to join for free
Sponsored
Stock saw a price change of 70.44% in past 5 days and over the past one month there was a price change of 37.56%. Year-to-date (YTD), EBS shares are showing a performance of 12.92% which decreased to -83.36% when we look at its performance for past 12 months. Over the period of past 52 weeks, stock dropped to lowest price of $1.42 but also hit the highest price of $16.66 during that period. The average intraday trading volume for Emergent Biosolutions Inc shares is 1.35 million. The stock is currently trading 60.64% above its 20-day simple moving average (SMA20), while that difference is up 33.92% for SMA50 and it goes to -40.25% lower than SMA200.
Emergent Biosolutions Inc (NYSE: EBS) currently have 50.10M outstanding shares and institutions hold larger chunk of about 79.33% of that.
The stock has a current market capitalization of $140.59M and its 3Y-monthly beta is at 0.98. It has posted earnings per share of -$15.65 in the same period. It has Quick Ratio of 0.54 while making debt-to-equity ratio of 1.26. Volatility of a stock is a metric used to know how much the price of that stock is under influence and for EBS, volatility over the week remained 26.62% while standing at 13.07% over the month.
Analysts are in expectations that Emergent Biosolutions Inc (EBS) stock would likely to be making an EPS of -$0.19 in the current quarter, while forecast for next quarter EPS is -$0.22 and it is $1.54 for next year. For the current quarter EPS, analysts have given the company a lowest target -$0.33 which is $0.07 at the higher side of the target for the same. When we compare those targets with actual EPS, we find that company posted an EPS of -$0.31 in the same quarter a year ago. Stock’s fiscal year EPS is expected to drop by -117.08% while it is estimated to increase by 131.78% in next year.
On April 10, 2023, The Benchmark Company Upgrade their recommendations, while on March 17, 2023, JP Morgan Downgrade their ratings for the stock with a price target of $9. Stock get a Hold rating from The Benchmark Company on November 10, 2022.
